Toggle navigation
norsk
English
English
norsk
English
Login
Toggle navigation
View Item
Home
Fakultet for medisin og helsevitenskap (MH)
Institutt for klinisk og molekylær medisin
View Item
Home
Fakultet for medisin og helsevitenskap (MH)
Institutt for klinisk og molekylær medisin
View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel
Chrisanthar, Ranjan
;
Knappskog, Stian
;
Løkkevik, Erik
;
Anker, Gun Birgitta
;
Østenstad, Bjørn
;
Lundgren, Steinar
;
Risberg, Terje
;
Mjaaland, Ingvil
;
Skjønsberg, Gudbrand
;
Aas, Turid
;
Schlichting, Ellen
;
Fjøsne, Hans Erikssønn
;
Nysted, Arne
;
Lillehaug, Johan R.
;
Lønning, Per Eystein
Journal article, Peer reviewed
View/
Open
546109_FULLTEXT01.pdf (579.4Kb)
URI
http://hdl.handle.net/11250/263530
Date
2011
Metadata
Show full item record
Collections
Institutt for klinisk og molekylær medisin
[3585]
Original version
10.1371/journal.pone.0019249
Publisher
Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisin
Journal
PLoS ONE
Search Archive
This Collection
Browse
Archive
Communities & Collections
By Issue Date
Authors
Titles
Subjects
Document Types
Journals
This Collection
By Issue Date
Authors
Titles
Subjects
Document Types
Journals
My Account
Login
Statistics
View Usage Statistics